Company Filing History:
Years Active: 1999
Title: The Innovations of Geoffrey Mark Lawrence
Introduction
Geoffrey Mark Lawrence is an accomplished inventor based in Sawbridgeworth, Great Britain. He holds a notable patent that has implications in medical therapeutics, offering insights into valuable biochemical processes.
Latest Patents
Lawrence's most significant patent is titled "Lipoprotein associated phospholipase A2, inhibitors thereof and use of". This patent focuses on the enzyme Lp-PLA2 in its purified form, detailing an isolated nucleic acid molecule that encodes for Lp-PLA2. Furthermore, it explores the use of inhibitors for the enzyme Lp-PLA2 in therapy and outlines a method for screening compounds that can identify potential inhibitors of this enzyme.
Career Highlights
Currently, Geoffrey Mark Lawrence is associated with SmithKline Beecham Corporation, where he continues to contribute to innovations in the biomedical field. His work in understanding and developing therapies related to Lp-PLA2 showcases his commitment to advancing healthcare solutions through scientific research.
Collaborations
Throughout his career, Lawrence has collaborated with notable colleagues, including Israel Simon Gloger and Simon Quentyn Rice. These partnerships highlight the collaborative spirit inherent in research and development, allowing for shared expertise and enhanced scientific discoveries.
Conclusion
Geoffrey Mark Lawrence's contributions to the field of biochemistry through his innovative patent underscore the crucial role of inventors in advancing medical science. With ongoing research and collaboration, Lawrence is poised to make lasting impacts in therapeutic development and biomedical research.